Healthcare / Medical Care FacilitiesKuala Lumpur
$0.10
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 21%
FCF escenarios
weak_data · normalized FCF $-70500.00 · quality 51.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
16/100
F
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$25M
P/E
N/A
•EV/EBITDA
42.5x
↑ROE
-0.4%
↓Gross Margin
46.5%
↓Debt/Equity
0.36
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2021–2025 · 4 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
—
FCF margin
-0.6%
FCF / Net income
1.47x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $27.4M · net income $-118000.0 · FCF $-173000.0
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | $27.4M | $27.4M | $29.3M | $35.3M | $34.5M | — |
| Net Income | $-118000.00 | $-118000.00 | $-3.7M | $91000.00 | $1.0M | — |
| EBITDA | $1.0M | $1.0M | $-2.2M | $4.6M | $7.2M | — |
| EPS | -0.00 | -0.00 | — | 0.00 | 0.00 | -0.01 |
| Gross Margin | 46.5% | 46.5% | 45.1% | 51.0% | 56.0% | — |
| Operating Margin | 3.0% | 3.0% | -7.4% | 3.5% | 7.6% | — |
| Net Margin | -0.4% | -0.4% | -12.5% | 0.3% | 2.9% | — |
| Balance Sheet | ||||||
| Debt/Equity | 0.36 | 0.36 | — | 0.36 | 0.50 | 0.34 |
| Current Ratio | 1.54 | 1.54 | — | — | — | — |
| Cash Flow | ||||||
| Free Cash Flow | $-173000.00 | $-173000.00 | — | $32000.00 | $-287000.00 | $5.0M |
| Returns | ||||||
| ROE | -0.4% | -0.4% | — | 0.3% | 3.0% | — |
| Valuation | ||||||
| P/E | — | — | — | 653.85 | 66.67 | — |
| EV/EBITDA | 42.50 | 42.50 | — | 15.28 | 11.30 | — |
| P/B | 1.20 | 1.20 | — | 1.78 | 2.00 | 1.51 |
| Growth & Yield | ||||||
| Revenue Growth | -6.6% | -6.6% | -17.1% | 2.4% | — | — |
| EPS Growth | — | — | — | -90.9% | 140.1% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-23.1%
Start / end P/E
n/dx → n/dx
EPS bridge
n/d → -0.00
Residual
-23.1%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.